Concomitant quantification of targeted drug delivery and biological response in individual cells

BioTechniques

Volumn 43, Issue 1, 2007, Pages 64-71

  Pinto, Massimo ^a   Howell, Roger W ^a,b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSES; CUMULATIVE LABELING INDEX; IMMUNOFLUORESCENCE; THERAPEUTIC AGENT;

BIOASSAY; DRUG DELIVERY; FLOW CYTOMETRY; IONIZING RADIATION; SKIN;

CELLS;

BROXURIDINE; DEOXYCYTIDINE; DNA;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CONFOCAL MICROSCOPY; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG UPTAKE; ELECTRON; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IONIZING RADIATION; LABELING INDEX; LASER CAPTURE MICROSCOPY; LASER SCANNING CYTOMETRY; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIOACTIVITY; SKIN FIBROBLAST; VALIDATION PROCESS;

ANTIBODY SPECIFICITY; BROMODEOXYURIDINE; BYSTANDER EFFECT; CELLS, CULTURED; DNA; DNA REPLICATION; DRUG DELIVERY SYSTEMS; FIBROBLASTS; FLOW CYTOMETRY; G2 PHASE; HUMANS; IDOXURIDINE; RADIATION, IONIZING; RADIOMETRY; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING;

EID: 34447643581     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112492     Document Type: Article

References (23)

1. Lumniczky, K. and G. Safrany. 2006. Cancer gene therapy: combination with radiation therapy and the role of bystander cell killing in the anti-tumor effect. Pathol. Oncol. Res. 12:118-124.
2. Wright, E.G. and P.J. Coates. 2006. Untargeted effects of ionizing radiation: implications for radiation pathology. Mutat. Res. 597:119-132.
3. Azzam, E.I., S.M. de Toledo, and J.B. Little. 2004. Stress signaling from irradiated to non-irradiated cells. Curr. Cancer Drug Targets 4:53-64.
4. Artemov, D., M. Solaiyappan, and Z.M. Bhujwalla. 2001. Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors. Cancer Res. 61:3039-3044.
5. Panyam, J., S.K. Sahoo, S. Prabha, T. Bargar, and V. Labhasetwar. 2003. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. Int. J. Pharm. 262:1-11.
6. Kvinnsland, Y., T. Stokke, and E. Aurlien. 2001. Radioimmunotherapy with alpha-particle emitters: microdosimetry of cells with a heterogeneous antigen expression and with various diameters of cells and nuclei. Radiat. Res. 155:288-296.
7. Editorial. 2006. Going single, but not alone. Nat. Methods 3:581.
8. Pinto, M., E.I. Azzam, and R.W. Howell. 2006. Bystander responses in three-dimensional cultures containing radiolabeled and unlabelled human cells. Radiat. Prot Dosimetry. 122:252-255.
9. Raju, M.R., Y. Eisen, S. Carpenter, K. Jarrett, and W.F. Harvey. 1993. Radiobiology of alpha particles. IV. Cell inactivation by alpha particles of energies 0.4-3.5 MeV. Radiat. Res. 133:289-296.
10. Goddu, S.M., R.W. Howell, L.G. Bouchet, W.E. Bolch, and D.V. Rao. 1997. MIRD Cellular S values: self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments. Society of Nuclear Medicine, Reston, VA.
11. National Council on Radiation Protection and Measurements (NCRP). 1979. Tritium and other radionuclide labeled organic compounds incorporated in genetic material. NCRP Report 3. NCRP, Washington, DC.
12. Feinendegen, L.E. 1967. Tritium-Labeled Molecules in Biology and Medicine. Academic Press, New York.
13. Schutte, B., M.M. Reynders, C.L. van Assche, P.S. Hupperets, F.T. Bosman, and G.H. Blijham. 1987. An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry. Cytometry 8:372-376.
14. Wersto, R.P., F.J. Chrest, J.F. Leary, C. Morris, M.A. Stetler-Stevenson, and E. Gabrielson. 2001. Doublet discrimination in DNA cell-cycle analysis. Cytometry 46:296-306.
15. Gonchoroff, N.J., J.A. Katzmann, R.M. Currie, E.L. Evans, D.W. Houck, B.C. Kline, P.R. Greipp, and M.R. Loken. 1986. S-phase detection with an antibody to bromo-deoxyuridine. Role of DNase pretreatment. J. Immunol. Methods 93:97-101.
16. Bishayee, A., D.V. Rao, and R.W. Howell. 1999. Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model. Radiat. Res. 152:88-97.
17. Maity, A., W.G. McKenna, and R.J. Muschel. 1994. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother. Oncol. 31:1-13.
18. Nagasawa, H., P. Keng, C. Maki, Y. Yu, and J.B. Little. 1998. Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection. Cancer Res. 58:2036-2041.
19. Vega, C.J. and D.A. Peterson. 2005. Stem cell proliferative history in tissue revealed by temporal halogenated thymidine analog discrimination. Nat. Methods 2:167-169.
20. 125I. Micron 33:127-132.
21. Gerashchenko, B.I. and R.W. Howell. 2003. Flow cytometry as a strategy to study radiation-induced bystander effects in co-culture systems. Cytometry 54A:1-7.
22. Neti, P.V. and R.W. Howell. 2006. Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals. J. Nucl. Med. 47:1049-1058.
23. van Dillen, I.J., N.H. Mulder, W. Vaalburg, E.F. de Vries, and G.A. Hospers. 2002. Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr. Gene Ther. 2:307-322.